Jan-07-21 Initiated
BTIG Research
Buy
$25
Jul-14-20 Initiated
Citigroup
Neutral
$20
May-21-20 Initiated
Guggenheim
Buy
$22
Apr-13-20 Initiated
SVB Leerink
Outperform
Oct-16-19 Initiated
Citigroup
Buy
$21
Aug-26-19 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$22
Dec-20-18 Upgrade
Morgan Stanley
Underweight → Equal-Weight
Mar-14-18 Downgrade
Morgan Stanley
Equal-Weight → Underweight
Sep-12-17 Upgrade
Morgan Stanley
Underweight → Equal-Weight
Feb-13-17 Downgrade
BofA/Merrill
Neutral → Underperform
Dec-20-16 Downgrade
KeyBanc Capital Mkts
Overweight → Sector Weight
Dec-13-16 Downgrade
Wells Fargo
Outperform → Market Perform
Oct-25-16 Initiated
First Analysis Sec
Equal-Weight
$14
Aug-04-16 Downgrade
Piper Jaffray
Neutral → Underweight
Aug-04-16 Downgrade
Goldman
Buy → Neutral
Apr-21-16 Downgrade
Robert W. Baird
Outperform → Neutral
$22 → $21
Mar-30-16 Downgrade
Morgan Stanley
Equal-Weight → Underweight
Mar-29-16 Initiated
KeyBanc Capital Mkts
Overweight
$26
Aug-07-15 Upgrade
Wells Fargo
Market Perform → Outperform
May-15-15 Upgrade
Goldman
Neutral → Buy
Mar-31-21 07:55AM
Mar-24-21 12:38PM
Mar-23-21 10:24AM
Mar-22-21 07:55AM
Mar-08-21 03:20PM
Mar-05-21 01:02AM
Feb-23-21 08:00AM
Feb-08-21 07:55AM
Feb-03-21 06:15PM
05:42PM
04:10PM
03:15PM
Jan-26-21 07:55AM
Jan-20-21 07:55AM
Jan-19-21 02:05AM
Jan-11-21 07:55AM
Jan-06-21 07:55AM
Jan-05-21 08:13AM
07:55AM
Jan-04-21 07:55AM
Dec-18-20 09:34AM
Dec-14-20 12:37PM
Dec-05-20 03:53AM
Dec-02-20 07:55AM
Nov-17-20 07:55AM
Nov-09-20 08:43AM
Nov-02-20 10:04AM
07:55AM
Oct-30-20 08:33AM
Oct-28-20 06:35PM
04:10PM
Oct-22-20 11:14AM
Oct-21-20 12:33PM
Oct-14-20 07:55AM
Oct-01-20 09:00AM
Sep-24-20 07:55AM
Sep-15-20 07:55AM
Sep-08-20 07:55AM
Sep-07-20 03:36PM
Aug-24-20 07:55AM
Jul-29-20 07:35PM
04:10PM
Jul-23-20 10:27AM
07:55AM
Jul-22-20 12:33PM
Jul-14-20 09:57AM
07:55AM
Jun-26-20 02:25PM
Jun-16-20 09:30AM
Jun-10-20 07:55AM
Jun-04-20 07:55AM
May-27-20 04:34PM
07:55AM
May-21-20 07:55AM
May-19-20 07:55AM
May-18-20 07:55AM
Apr-30-20 09:23PM Thomson Reuters StreetEvents
02:02AM
Apr-29-20 06:25PM
04:10PM
Apr-22-20 12:31PM
08:35AM
Apr-15-20 07:55AM
Apr-09-20 09:11AM American City Business Journals
Mar-28-20 08:37PM
Mar-23-20 07:55AM
Mar-17-20 09:30AM
08:21AM
07:55AM
Mar-03-20 07:55AM
Mar-02-20 02:16PM
10:18AM
Feb-24-20 07:55AM
Feb-20-20 04:14PM Thomson Reuters StreetEvents -5.12%
Feb-19-20 05:55PM
04:10PM
Feb-12-20 12:31PM
Feb-11-20 07:55AM
Feb-10-20 12:28PM
Feb-05-20 07:55AM
Jan-14-20 07:55AM
Jan-13-20 07:55AM
Jan-06-20 07:55AM
Jan-03-20 07:55AM
Dec-14-19 09:13PM
Dec-12-19 08:06AM
Nov-05-19 09:00AM
Nov-04-19 07:55AM
Oct-31-19 04:13PM Thomson Reuters StreetEvents +10.62%
Oct-30-19 08:45PM
04:10PM
Oct-28-19 11:39AM
07:55AM
Oct-26-19 09:39PM
Oct-23-19 10:34AM
Oct-16-19 07:55AM
Sep-26-19 12:36PM
Aug-27-19 07:55AM
05:54AM
Aug-26-19 12:34PM
Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, an integrated, real-time cloud native platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately one million physicians; 574,000 clinical facilities; and approximately 332 million individuals and 61 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PULIDO MARK Director Feb 05 Sale 26.39 100,000 2,639,310 254,760 Feb 09 08:30 PM Boldt Jonathan R Chief Financial Officer Jan 12 Sale 22.80 996 22,709 278,409 Jan 14 05:39 PM Boldt Jonathan R Chief Financial Officer Dec 17 Sale 19.08 2,500 47,700 279,405 Dec 17 05:04 PM Boldt Jonathan R Chief Financial Officer Dec 16 Sale 19.12 2,500 47,800 281,905 Dec 17 05:04 PM Boldt Jonathan R Chief Financial Officer Dec 15 Sale 19.48 2,500 48,700 284,405 Dec 17 05:04 PM Boldt Jonathan R Chief Financial Officer Nov 19 Sale 18.40 2,500 46,000 234,190 Nov 19 05:50 PM Boldt Jonathan R Chief Financial Officer Nov 18 Sale 18.63 2,500 46,575 236,690 Nov 19 05:50 PM Boldt Jonathan R Chief Financial Officer Nov 17 Sale 18.24 2,500 45,600 239,190 Nov 19 05:50 PM De Bock Peter Chief Administrative Officer Oct 30 Buy 19.03 15,000 285,450 173,486 Nov 02 06:08 AM TEUBER WILLIAM J JR Director Oct 30 Buy 19.48 10,000 194,780 144,247 Nov 02 06:05 AM Dunleavy Keith R CEO and Chairman of the Board Oct 30 Buy 19.62 60,000 1,177,140 660,000 Nov 02 06:02 AM Boldt Jonathan R Chief Financial Officer Oct 15 Sale 26.74 5,334 142,631 242,361 Oct 15 08:26 PM Boldt Jonathan R Chief Financial Officer Oct 14 Sale 26.92 5,334 143,591 247,695 Oct 15 08:26 PM Boldt Jonathan R Chief Financial Officer Oct 13 Sale 27.16 5,334 144,871 253,029 Oct 15 08:26 PM Boldt Jonathan R Chief Financial Officer Sep 17 Sale 24.92 4,334 108,003 258,363 Sep 17 05:25 PM Boldt Jonathan R Chief Financial Officer Sep 16 Sale 24.79 4,334 107,440 262,697 Sep 17 05:25 PM Boldt Jonathan R Chief Financial Officer Sep 15 Sale 24.85 4,334 107,700 267,031 Sep 17 05:25 PM Capitel Jason Chief Commercial Officer Aug 05 Sale 25.18 20,000 503,600 556,504 Aug 05 07:09 PM Capitel Jason Chief Operating Officer May 28 Sale 19.28 15,000 289,200 596,504 May 28 05:43 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite